Iris Walraven

1.5k citations

67 papers · 939 indexed · h-index 18

Radiation top 5%
- Advanced Radiotherapy Techniques 9
Otorhinolaryngology top 5%
Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Diagnosis and Treatment 16
- Lung Cancer Treatments and Mutations 12
- Prostate Cancer Diagnosis and Treatment 6
Oncology top 10%
- Cancer survivorship and care 9
- Lung Cancer Research Studies 8
Radiology, Nuclear Medicine and Imaging top 10%
- Radiomics and Machine Learning in Medical Imaging 6
Pediatrics, Perinatology and Child Health
- Childhood Cancer Survivors' Quality of Life 6

Co-authors: J. Belderbos Floris J. Pos Uulke A. van der Heide Joost Dekker Giel Nijpels Marcel Verheij Else A. Aalbersberg Petra J. M. Elders
Cited by: Radiation Otorhinolaryngology Pulmonary and Respiratory Medicine
Journals: Radiotherapy and Oncology (8 papers)Cancers (4 papers)Cancer (3 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Iris Walraven

61 papers receiving 930 citations

Peers

Countries citing papers authored by Iris Walraven

Since Specialization

Citations

This map shows the geographic impact of Iris Walraven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Walraven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Walraven more than expected).

Fields of papers citing papers by Iris Walraven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Walraven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Walraven. The network helps show where Iris Walraven may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Iris Walraven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Iris Walraven Line = papers co-authored together Iris Walraven links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Moving beyond barriers: a mixed-method study to develop evidence-based strategies to improve implementation of PROMs in clinical oncology care Quality of Life Research ·A. Bagrodia,Iris Walraven,Iris M. C. van der Ploeg,Michel W.J.M. Wouters,Σ. Βασιλειάδης,Richard Dirven,李树贤,Pam Bolin,Wing K Lau,Lonneke V. van de Poll‐Franse,Kelly M. de Ligt	2024	2
2	Which patients are at risk of developing symptom diagnoses that persist for more than a year in primary care? Development and external validation of a prediction model Journal of Psychosomatic Research ·木村千明,Marek Mastilák,Reinier Akkermans,Kees van Boven,Iris Walraven,Marco H. Blanker,Henk Schers,Tim olde Hartman	2024	1
3	Using a modified Delphi procedure to select a PRO-CTCAE-based subset for patient-reported symptomatic toxicity monitoring in rectal cancer patients Quality of Life Research ·A Escola,Femke P. Peters,Esther Feldman,Jeanine M.L. Roodhart,Milan C. Richir,Jan Willem T. Dekker,Geerard L. Beets,Jeltsje S. Cnossen,Hauge Sn,Martijn Intven,Marcel Verheij,Kelly M. de Ligt,Iris Walraven	2024	1
4	Reproductive outcomes and reproductive health care utilization among male survivors of childhood cancer: A DCCSS‐LATER study Cancer ·赵欣月,Aaron Masjedi,Ewald M. Bronkhorst,Leontien C.M. Kremer,Eline van Dulmen‐den Broeder,Margriet van der Heiden‐van der Loo,Wim J. E. Tissing,Helena J. H. van der Pal,Nicole M. A. Blijlevens,Marry M. van den Heuvel‐Eibrink,Birgitta Versluys,Dorine Bresters,Cécile M. Ronckers,Iris Walraven,C. C. M. Beerendonk,Jacqueline J. Loonen,(unknown)	2023	1
5	Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure ESMO Open ·Erica Feldman,Floris J. Pos,Robert Jan Smeenk,Henk G. van der Poel,Pim van Leeuwen,Jeantine M. de Feijter,Maarten C.C.M. Hulshof,Tom Budiharto,Rosella Hermens,Kelly M. de Ligt,Iris Walraven	2023	7
6	Patients’ Characteristics and General Practitioners’ Management of Patients with Symptom Diagnoses The Journal of the American Board of Family Medicine ·木村千明,Marek Mastilák,Iris Walraven,Kees van Boven,H. Peters,Henk Schers,Tim olde Hartman	2023	9
7	Patient-reported symptom monitoring linked to an alert algorithm: Effects on progression-free and overall survival in the SYMPRO-Lung trial. Journal of Clinical Oncology ·Ludovic Alexandru Szanto,Corina van den Hurk,祥二東,Neil K. Aaronson,J. Belderbos,Harm Jan Bogaard,Jacqueline G. Hugtenburg,Bregje D. Onwuteaka‐Philipsen,Lonneke V. van de Poll‐Franse,Iris Walraven,Annemarie Becker‐Commissaris	2023	0
8	A Narrative Review on the Collection and Use of Electronic Patient-Reported Outcomes in Cancer Survivorship Care with Emphasis on Symptom Monitoring Current Oncology ·Corina van den Hurk,Floortje Mols,Manuela Eicher,Raymond J. Chan,Annemarie Becker‐Commissaris,Gijs Geleijnse,Iris Walraven,Annemarie Coolbrandt,Maryam B. Lustberg,Galina Velikova,Andreas Charalambous,Bogda Koczwara,Doris Howell,Ethan Basch,Lonneke V. van de Poll‐Franse	2022	26
9	Visualization formats of patient-reported outcome measures in clinical practice: a systematic review about preferences and interpretation accuracy Journal of Patient-Reported Outcomes ·李树贤,Pam Bolin,Iris Walraven,Erica A. Wilthagen,Sanne B. Schagen,Vivian Hauff,Michel W.J.M. Wouters,Lonneke V. van de Poll‐Franse,Kelly M. de Ligt	2022	23
10	Varying severities of symptoms underline the relevance of personalized follow-up care in breast cancer survivors: latent class cluster analyses in a cross-sectional cohort Supportive Care in Cancer ·Kelly M. de Ligt,Belle H. de Rooij,Iris Walraven,M. Heins,Janneke Verloop,Sabine Siesling,Joke C. Korevaar,Lonneke V. van de Poll‐Franse	2022	10
11	Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study JMIR Cancer ·H. Schwall,Iris Walraven,J. Belderbos	2021	7
12	SYMptom monitoring with Patient-Reported Outcomes using a web application among patients with Lung cancer in the Netherlands (SYMPRO-Lung): study protocol for a stepped-wedge randomised controlled trial BMJ Open ·Ludovic Alexandru Szanto,祥二東,H. Schwall,J. Belderbos,Neil K. Aaronson,Esther Feldman,V. V. Bagatinskaya,Harm Jan Bogaard,Bregje D. Onwuteaka‐Philipsen,Lonneke V. van de Poll‐Franse,Jacqueline G. Hugtenburg,Corina van den Hurk,Annemarie Becker‐Commissaris,Iris Walraven	2021	10
13	134P_PR Towards tailored follow-up care for breast cancer survivors: Cluster analyses based on symptom burden Annals of Oncology ·Kelly M. de Ligt,Belle H. de Rooij,Iris Walraven,M. Heins,Sabine Siesling,Joke C. Korevaar,Lonneke V. van de Poll‐Franse	2021	1
14	Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy Cancer Imaging ·晃明柴田,Else A. Aalbersberg,Michelle W. J. Versleijen,Margot Tesselaar,Iris Walraven,Max J. Lahaye,Berlinda J. de Wit–van der Veen,Marcel P. M. Stokkel	2020	41
15	The prognostic value of volumetric changes of the primary tumor measured on Cone Beam-CT during radiotherapy for concurrent chemoradiation in NSCLC patients Radiotherapy and Oncology ·Margriet Kwint,俞建洪,Cécile Proust‐Lima,Scriptorvm Graecorvm,Trynke Hoekstra,Else A. Aalbersberg,Maddalena Rossi,Jan‐Jakob Sonke,J. Belderbos,Iris Walraven	2020	9
16	Pre-hydration in cisplatin-based CCRT: Effects on tumour concentrations and treatment outcome Radiotherapy and Oncology ·Else A. Aalbersberg,Maddalena Rossi,Berlinda J. de Wit–van der Veen,Iris Walraven,Michel M. van den Heuvel,Jan‐Jakob Sonke,J. Belderbos,Wouter V. Vogel	2019	5
17	Outcome of radical local treatment of non-small cell lung cancer patients with synchronous oligometastases Lung Cancer ·Margriet Kwint,Iris Walraven,Sjaak Burgers,Koen J. Hartemink,Houke M. Klomp,J. Knegjens,Marcel Verheij,J. Belderbos	2017	30
18	Treatment Variation of Sequential versus Concurrent Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer Patients in the Netherlands and Belgium Clinical Oncology ·Iris Walraven,Ronald Damhuis,Martijn Geert ten Berge,Che‐Man Chan,Liesbet Van Eycken,Dirk De Ruysscher,J. Belderbos	2017	29
19	Self-reported hypoglycaemia in patients with type 2 diabetes treated with insulin in the Hoorn Diabetes Care System Cohort, the Netherlands: a prospective cohort study BMJ Open ·Simone P. Rauh,Femke Rutters,Brian Larsen Thorsted,Michael Lyng Wolden,Giel Nijpels,Amber A. van der Heijden,Iris Walraven,Petra J. M. Elders,Martijn W. Heymans,Joost Dekker	2016	8
20	Low-grade inflammation and endothelial dysfunction explain the association between retinopathy and left ventricular ejection fraction in men: an 8-year follow-up of the Hoorn Study Journal of Diabetes and its Complications ·Iris Walraven,Katja van den Hurk,Esther van ‘t Riet,Otto Kamp,Casper G. Schalkwijk,Coen D.A. Stehouwer,Walter J. Paulus,Annette C. Moll,Joost Dekker,B.C.P. Polak,Giel Nijpels	2014	9

About Iris Walraven

Iris Walraven is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Radiation, Family Practice and Oncology, having authored 67 papers that have together received 939 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (12 papers), Advanced Radiotherapy Techniques (9 papers), Cancer survivorship and care (9 papers), Lung Cancer Research Studies (8 papers), Childhood Cancer Survivors' Quality of Life (6 papers), Prostate Cancer Diagnosis and Treatment (6 papers) and Radiomics and Machine Learning in Medical Imaging (6 papers). The work is most often cited by research in Radiation (143 citations), Otorhinolaryngology (71 citations), Pulmonary and Respiratory Medicine (479 citations), Oncology (251 citations) and Radiology, Nuclear Medicine and Imaging (203 citations). Iris Walraven has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include J. Belderbos, Floris J. Pos, Uulke A. van der Heide, Joost Dekker, Giel Nijpels, Marcel Verheij, Else A. Aalbersberg, Petra J. M. Elders, Berlinda J. de Wit–van der Veen and Amber A. van der Heijden. Their work appears in journals such as Radiotherapy and Oncology, Cancers, Cancer, Annals of Oncology and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact